Celsius Therapeutics collaborates with Janssen Biotech

Cyxone announces submission of first RA application for clinical phase IIb trial with Rabeximod

GSK starts phase III clinical development programme with otilimab

Viela Bio Names Chan as Chief Financial Officer

Alexion Receives FDA Approval of Soliris for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) who are Anti-Aquaporin-4 Antibody Positive

Alexion Pharmaceuticals' Soliris approved by US FDA

FDA clears first treatment for neuromyelitis optica spectrum disorder

Navidea Biopharmaceuticals Raises USD 6m from Public Offering of Common Stock

FDA Approves US Merck's Keytruda as Monotherapy for Patients with Metastatic Small Cell Lung Cancer with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy

Viela Bio Raises USD 75m in Series B Financing

Navidea Biopharmaceuticals concludes USD6m public offering

Navidea Biopharmaceuticals Plans Public Stock Offering

Navidea Biopharmaceuticals Prices USD 6m Public Offering of Common Stock

Phase III PEMPHIX Study Showed That Genentech's Rituxan is Superior to Standard of Care in Achieving Sustained Remission in Patients with Pemphigus Vulgaris

Janssen Presents New Data Showing Sustained Clinical Benefit and Reduction in Severe Flares with Stelara in Patients with Systemic Lupus Erythematosus